Skip to content

Study · Animal study (in vivo) · 2007

2 results

Experimental study of the pharmacokinetics of a tryptophan-containing dipeptide GB-115.

Boyko SS, Kolyvanov GB, Zherdev VP, Gudasheva TA, Kiryanova EP, Seredenin SB

Bulletin of experimental biology and medicine1 Sept 2007Cited by 3 (Europe PMC)

PMID18457023 (opens in a new tab)DOI10.1007/s10517-007-0319-0 (opens in a new tab)PepBankPUB-18457023
Publisher pagePubMedAsk about this study
Jump to 2 results

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study2

2 results from studies that gave the peptide. No result from this study comes from people.

  1. 01AnimalAnimal study (in vivo)Pharmacokinetics

    In the pharmacokinetic study, GB‑115 was resistant to peptidases.

    In plain wordsIn the pharmacokinetic study, GB‑115 resisted breakdown by peptidases. The abstract does not identify the species.

    Peptide
    GB-115
    Outcome
    Not applicableResistance to peptidases
    Study

    n: not reported in source

    Outcome group
    Pharmacokinetics · Pharmacology
    Studied dose
    Dose not stated

    Source sentences

    Summary
    Our results indicate that this dipeptide is resistant to peptidases.
    1 context sentence
    Summary · context
    Pharmacokinetic parameters were calculated after intravenous and peroral administration of GB-115.
  2. 02AnimalAnimal study (in vivo)Pharmacokinetics

    In the pharmacokinetic study, GB‑115 had an absolute bioavailability of 4.65%.

    In plain wordsIn the pharmacokinetic study, GB‑115 had an absolute bioavailability of 4.65%. The abstract does not identify the species.

    Peptide
    GB-115
    Outcome
    Not applicableAbsolute bioavailability
    Study

    n: not reported in source

    Outcome group
    Pharmacokinetics · Pharmacology
    Studied dose
    Dose not stated

    Measurements

    Absolute bioavailability
    4.65%
    GB-115

    Source sentences

    Summary
    The absolute bioavailability of GB-115 is 4.65%.
    1 context sentence
    Summary · context
    Pharmacokinetic parameters were calculated after intravenous and peroral administration of GB-115.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    27 Oct 2026, 18:20 UTC

    Study results updated

  2. Version 1

    27 Oct 2026, 16:32 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

Publication types

PepBank is a research reference. Talk to a doctor before you use any peptide.